14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 VCEL stock ended at $47.83. This is 0.104% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.03% from a day low at $47.56 to a day high of $49.00.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Vericel Corporation prices

Date Open High Low Close Volume
Mar 28, 2024 $52.44 $52.50 $51.66 $52.02 473 781
Mar 27, 2024 $50.25 $52.42 $50.25 $52.33 553 958
Mar 26, 2024 $48.13 $49.72 $48.13 $49.56 744 866
Mar 25, 2024 $47.06 $48.34 $46.99 $47.94 767 149
Mar 22, 2024 $46.90 $47.28 $45.59 $46.90 827 754
Mar 21, 2024 $46.00 $46.91 $45.82 $46.69 721 419
Mar 20, 2024 $45.27 $46.00 $44.45 $45.75 382 529
Mar 19, 2024 $44.15 $45.69 $44.15 $45.63 283 183
Mar 18, 2024 $44.20 $44.63 $43.48 $44.19 353 523
Mar 15, 2024 $43.98 $44.92 $43.98 $44.26 1 073 936
Mar 14, 2024 $44.05 $44.64 $43.68 $44.21 401 656
Mar 13, 2024 $44.42 $45.08 $44.18 $44.51 266 375
Mar 12, 2024 $44.24 $45.05 $44.24 $44.40 300 041
Mar 11, 2024 $44.90 $45.43 $44.08 $44.59 532 242
Mar 08, 2024 $45.31 $46.10 $44.75 $45.20 279 533
Mar 07, 2024 $45.69 $46.08 $44.72 $44.82 237 424
Mar 06, 2024 $44.87 $45.71 $44.32 $45.18 335 754
Mar 05, 2024 $44.69 $44.84 $43.96 $44.46 330 449
Mar 04, 2024 $44.89 $45.22 $44.32 $44.77 386 261
Mar 01, 2024 $46.43 $46.91 $44.45 $44.71 461 555
Feb 29, 2024 $49.23 $49.89 $43.87 $45.68 895 195
Feb 28, 2024 $47.42 $48.46 $47.41 $47.80 512 145
Feb 27, 2024 $48.24 $48.79 $47.96 $48.00 385 302
Feb 26, 2024 $46.94 $48.34 $46.53 $48.08 243 870
Feb 23, 2024 $48.26 $48.52 $47.20 $47.32 270 639
Click to get the best stock tips daily for free!

About Vericel Corporation

Vericel Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epic... VCEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT